These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study. Stolke D; Seifert V Neurosurgery; 1992 Jun; 30(6):877-81. PubMed ID: 1614590 [TBL] [Abstract][Full Text] [Related]
6. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. Ohman J; Servo A; Heiskanen O J Neurosurg; 1991 Aug; 75(2):197-201. PubMed ID: 1906535 [TBL] [Abstract][Full Text] [Related]
7. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage. Kinouchi H; Ogasawara K; Shimizu H; Mizoi K; Yoshimoto T Neurol Med Chir (Tokyo); 2004 Nov; 44(11):569-75; discussion 576-7. PubMed ID: 15686175 [TBL] [Abstract][Full Text] [Related]
8. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. Zabramski JM; Spetzler RF; Lee KS; Papadopoulos SM; Bovill E; Zimmerman RS; Bederson JB J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534 [TBL] [Abstract][Full Text] [Related]
9. Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage. Steinberg GK; Vanefsky MA; Marks MP; Adler JR; Koenig GH Neurosurgery; 1994 May; 34(5):809-13; discussion 813-4. PubMed ID: 8052377 [TBL] [Abstract][Full Text] [Related]
10. A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Sasaki T; Ohta T; Kikuchi H; Takakura K; Usui M; Ohnishi H; Kondo A; Tanabe H; Nakamura J; Yamada K Neurosurgery; 1994 Oct; 35(4):597-604; discussion 604-5. PubMed ID: 7808602 [TBL] [Abstract][Full Text] [Related]
11. Effect of clot removal and surgical manipulation on regional cerebral blood flow and delayed vasospasm in early aneurysm surgery for subarachnoid hemorrhage. Hosoda K; Fujita S; Kawaguchi T; Shose Y; Hamano S; Iwakura M Surg Neurol; 1999 Jan; 51(1):81-8. PubMed ID: 9952128 [TBL] [Abstract][Full Text] [Related]
12. Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients. Kodama N; Sasaki T; Kawakami M; Sato M; Asari J Surg Neurol; 2000 Feb; 53(2):110-7; discussion 117-8. PubMed ID: 10713187 [TBL] [Abstract][Full Text] [Related]
13. Prevention of delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage by intrathecal bolus injection of tissue plasminogen activator (rTPA). A prospective study. Seifert V; Stolke D; Zimmermann M; Feldges A Acta Neurochir (Wien); 1994; 128(1-4):137-43. PubMed ID: 7847131 [TBL] [Abstract][Full Text] [Related]
14. [Preliminary clinical trial of intrathecal rt-PA (TD-2061) for the prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage]. Sasaki T; Ohta T; Kikuch H; Takakura K; Usui M; Kondoh A; Tanabe H; Nakamura J; Yamada K No To Shinkei; 1992 Nov; 44(11):1001-8. PubMed ID: 1296711 [TBL] [Abstract][Full Text] [Related]
15. Early treatment of subarachnoid hemorrhage after preventing rerupture of an aneurysm. Kinugasa K; Kamata I; Hirotsune N; Tokunaga K; Sugiu K; Handa A; Nakashima H; Ohmoto T; Mandai S; Matsumoto Y J Neurosurg; 1995 Jul; 83(1):34-41. PubMed ID: 7782847 [TBL] [Abstract][Full Text] [Related]
16. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685 [TBL] [Abstract][Full Text] [Related]
17. Innovations in aneurysmal subarachnoid hemorrhage: intracisternal t-PA for the prevention of vasospasm. Bell TE; Kongable GL J Neurosci Nurs; 1996 Apr; 28(2):107-13. PubMed ID: 8718759 [TBL] [Abstract][Full Text] [Related]
18. Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model. Hariton GB; Findlay JM; Weir BK; Kasuya H; Grace MG; Mielke BW Neurosurgery; 1993 Oct; 33(4):691-6; discussion 696-7. PubMed ID: 8232810 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Seifert V; Eisert WG; Stolke D; Goetz C Neurosurgery; 1989 Oct; 25(4):590-8. PubMed ID: 2507953 [TBL] [Abstract][Full Text] [Related]
20. Influence of intraoperative using of recombinant tissue plasminogen activator on the development of cerebral angiospasm after subarachnoid haemorrhage in patients with ruptured intracranial aneurysms. Górski R; Zabek M; Jarmuzek P Neurol Neurochir Pol; 2000; 34(6 Suppl):41-7. PubMed ID: 11452854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]